ReviewWorld journal of nephrology2025
Antimicrobial dosing considerations in critically ill patients with acute kidney injury: A review.
Review in World journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Targeting integrated cell death networks in sepsis‑associated acute kidney injury: Shared regulatory nodes and diet‑related small molecule modulation (Review).International journal of molecular medicine · 2026Review
- Inappropriate Antimicrobial Dosing in Regard to Renal Function in a Tertiary Hospital in Greece-A Single-Center Point Prevalence Study.Medicina (Kaunas, Lithuania) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis-associated acute kidney injury is common in critically ill patients and is strongly associated with an increased risk of adverse outcomes and mortality. While early and appropriate antimicrobials for sepsis have been associated with an increased probability of survival, adequate dosing is a challenge in these patients. Critical illness with acute kidney injury is characterized by marked physiological derangements. This impacts the pharmacokinetic and pharmacodynamic profiles of antimicrobials, which complicates the predictability of drug disposition. Conventional antimicrobial dosing may not be optimal in this patient population, leading to under or overexposure to antimicrobials. This review summarizes an overview of the drug dosing considerations and relevant evidence of appropriate dosing strategies of common antimicrobials encountered in critically ill patients with acute kidney injury to optimize therapeutic efficacy and to reduce toxicity and adverse events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.